Replies to post #4335 on Innovus Pharmaceuticals Inc. (fka INNV)

[TRUMPFORPRES]

If you are Patient enough, here is the run down for 2017(without any fluticare $). If company generates enough cash and no longer have amortized derivative expenses(non-cash transaction)

Sales 17M
COGS (3M) (If they hold 82% Margin)
--------------------
Gross Profit 14M
Marketing Fee (8M) 2M a quarter for the BH Platform
G&Admin (2M)
-------------------
Net Income 4M
Taxes 0 (Carryover losses will offset net incomes for few years)